Amgen 20. Apr. 2026 Pfizer, Amgen among 22 firms to expand in Hong Kong: SCMP (PFE:NYSE) - Seeking Alpha
FierceBiotech 16. Apr. 2026 Pfizer–backed Storm blows into $56M series C, launches phase 2 sarcoma trial
FierceBiotech 6. Apr. 2026 With Sanofi and Pfizer deals, Novavax bets on ‘amplification strategy’ to drive vaccines engine
FierceBiotech 1. Apr. 2026 Valneva CEO on Pfizer-partnered Lyme vaccine: Why a phase 3 miss doesn’t tell the whole story
FierceBiotech 1. Apr. 2026 Oric chases Pfizer into phase 3 hailing prostate cancer edge, but investors send stock down
BioPharma Dive 23. März 2026 Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results
FierceBiotech 23. März 2026 Pfizer, Valneva blame low Lyme cases for phase 3 vaccine fail but still plan approval push
FierceBiotech 19. März 2026 Pfizer adds to Seagen scrap heap with another early cancer candidate cull
Endpoints News 19. März 2026 Pfizer seeks earlier use of Talzenna in prostate cancer with Phase 3 win
FierceBiotech 12. März 2026 Pfizer Ignite, designed to accelerate promising biotech therapies, fizzles out
BioPharma Dive 6. März 2026 Pfizer nabs first obesity approval; Alnylam, Tenaya search for heart drugs
Endpoints News 6. März 2026 Pfizer gets obesity drug approval in China shortly after buying local rights